- Accreditations
- Virtual Tour
- Gallery
- Sustainability
Pharmaceutical Products Catalogue
Explore Viswa Laboratories’ comprehensive range of pharmaceutical products.
Product List
| # | Name | Case No | Use Case | Description |
|---|---|---|---|---|
| 1 | (1H-Indol-3-yl)(naphthalen-1-yl) methanone | 109555-87-5 | Intermediate | |
| 2 | (2S)-2-Oxiranylmethyl-isoindole-1,3-dione | 161596-47-0 | Rivaroxaban Intermediate | |
| 3 | (4S)-3-[5-(4-fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone | 189028-93-1 | Ezetimibe Intermediate | |
| 4 | 1-Acetylimidazolidin-2-one | 5391-39-9 | Tizanidine Intermediate | |
| 5 | 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine hydrochloride | 86604-75-3 | Omeprazole Intermediate | |
| 6 | 2-Mercapto-5-methoxybenzimidazole | 37052-78-1 | Omeprazole Intermediate | |
| 7 | 3-O-Ethyl ascorbic acid | 86404-04-8 | Cosmetics | |
| 8 | 4-(4-Amino-phenyl)-morpholin-3-one | 438056-69-0 | Rivaroxaban Intermediate | |
| 9 | 4-Amino-5-chloro-2,1,3 benzothiadiazole | 30536-19-7 / 115398-34-0 | Tizanidine Intermediate | |
| 10 | 4-Benzyloxy-3-nitro-alpha-bromoacetophenone | 43229-01-2 | Formoterol Intermediate | |
| 11 | 4-Methoxy-alpha-methyl-N-(phenylmethyl)benzeneethanamine hydrochloride | 1049695-95-5 | Formoterol Intermediate | |
| 12 | 4-[4-[4-(Pentyloxy)phenyl]phenyl]benzoic acid | 158938-08-0 | Anidulafungin Side Chain | |
| 13 | 4-[5-[4-(Pentyloxy)phenyl]-3-isoxazolyl]benzoic acid | 179162-55-1 | Micafungin Side Chain | |
| 14 | 5-Chloro-2-thiophenecarboxylic acid | 24065-33-6 | Rivaroxaban Intermediate | |
| 15 | 5-Methoxy-2-tetralone | 32940-15-1 | Rotigotine Intermediate | |
| 16 | 7-Hydroxy-3,4-dihydro-2(1H)-quinolinone | 22246-18-0 | Aripiprazole Intermediate | |
| 17 | Ethylene glycol di-p-tosylate | 6315-52-2 | Intermediate | |
| 18 | Etodolac methyl ester | 122188-02-7 | Intermediate | |
| 19 | Methyl 3-chloro-3-oxopropionate | 37517-81-0 | Advanced Intermediate | |
| 20 | Ethane-1,2 –diyl bis (4-metylbenzenesulfonate) | 6315-52-2 | Plerixafor Intermediate | |
| 21 | Phosphocholine chloride calcium salt | 4826-71-5 | Citicoline Intermediate | |
| 22 | 2,4,6-Trichloroborazine | 933-18-6 | Rare chemical | |
| 23 | 2'-Hydroxy-5'-Methyl Acetophenone | 1450-72-2 | Custom molecule | |
| 24 | GalNAc Derivatives - Under Development | mRNA therapeutics | ||
| 25 | Aziridine - Under Development | 151-56-4 | Building block | |
| 26 | Alfacalcidol | 41294-56-8 | API | Vitamin D analog – used in calcium/phosphate metabolism |
| 27 | Allopurinol | 315-30-0 / 916980-04-6 | API | Xanthine oxidase inhibitor – used for gout and hyperuricemia |
| 28 | Calcipotriol | 112965-21-6 | API | Vitamin D analog – used for psoriasis |
| 29 | Calcitriol | 32222-06-3 | API | Active form of Vitamin D – used in hypocalcemia, renal disease |
| 30 | Citicoline Sodium | 33818-15-4 | API | Nootropic – used in stroke recovery, cognitive impairment |
| 31 | Diacerein | 13739-02-1 | API | Anti-inflammatory – used in osteoarthritis |
| 32 | Etodolac | 41340-25-4 | API | NSAID – used in pain and inflammation |
| 33 | Febuxostat | 144060-53-7 | API | Xanthine oxidase inhibitor – used for chronic gout |
| 34 | Flavoxate | 15301-69-6 | API | Antispasmodic – used in urinary tract disorders |
| 35 | Flecainide | 54143-55-4 | API | Antiarrhythmic – used for atrial fibrillation, tachycardia |
| 36 | Lornoxicam | 70374-39-9 | API | NSAID – used in pain and inflammation |
| 37 | Monobenzone | 103-16-2 | API | Depigmenting agent – used in vitiligo |
| 38 | Olopatadine hydrochloride | 140462-76-6 | API | Antihistamine – used in allergic conjunctivitis |
| 39 | Phosphocholine chloride calcium salt | 4826-71-5 | API | Nutritional/pharmaceutical agent – membrane stabilizer |
| 40 | Probenecid | 57-66-9 | API | Uricosuric – used in gout, prolongs penicillin action |
| 41 | Propofol | 2078-54-8 | API | General anesthetic |
| 42 | Roflumilast | 162401-32-3 | API | PDE-4 inhibitor – used in COPD |
| 43 | Terbutaline sulfate | 23031-32-5 | API | Beta-2 agonist – used as bronchodilator |
| 44 | Ticagrelor | 274693-27-5 | API | Antiplatelet – used in acute coronary syndrome |
| 45 | Tizanidine hydrochloride | 64461-82-1 | API | Muscle relaxant – used in spasticity |
| 46 | Tolfenamic acid | 13710-19-5 | API | NSAID – used in migraines and inflammation |
| 47 | Trioxsalen | 3902-71-4 | API | Photosensitizing agent – used in vitiligo, psoriasis (PUVA) |
Security
A foundation built on data security
SOC 2 (Type II) SOC 3
GDPR
CCPA
Security governance
Viswa Laboratories employs a comprehensive framework to ensure the highest levels of security. From encrypted data handling to rigorous audits, we prioritize safeguarding sensitive information at every stage.
Identity and Access Management
Access to systems and data is tightly managed, with advanced tools enabling precise authorization for team members.
Infrastructure Monitoring and Resilience
Continuous monitoring and robust systems ensure real-time threat detection and rapid response to potential vulnerabilities.
Staff Training and Awareness
Our teams undergo regular security training to uphold best practices and ensure compliance across all levels of operation.
What We Offer
At Viswa Laboratories, we offer a range of specialized services designed to support pharmaceutical and biotech industries:
CRAMS
Comprehensive solutions for research, development, and scalable production.
APIs
High-quality API development with a focus on precision, purity, and regulatory compliance.
Intermediates
Reliable intermediates essential for API synthesis and drug development.
CS
Tailored chemical solutions to meet client-specific requirements with unmatched quality.
